Cipla Limited, one of India’s largest global pharmaceutical companies, has announced the re-appointment of Shri P R Ramesh as an Independent Director on its Board. A former Executive Chairman of Deloitte India, Ramesh brings nearly four decades of expertise in auditing, financial reporting, and corporate governance. His re-appointment, effective from early 2026, underscores Cipla’s commitment to maintaining a robust regulatory and financial oversight framework as it navigates the complex global pharmaceutical landscape.
